Most Recent Publications
1. Triebel J, Moreno-Vega AI, Vázquez-Membrillo M, Nava G, García-Franco R, López-Star E, Baldivieso-Hurtado O, Ochoa D, Macotela Y, Bertsch T, Martinez de la Escalera G, Clapp C., High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function., Clinical Laboratory, August 2015; 61(7), 709-16
2. Thebault S, González C, García C, Arredondo Zamarripa D, Nava G, Vaca L, López-Casillas F, Martínez De La Escalera G, Clapp C., Vasoinhibins prevent bradykinin-stimulated endothelial cell proliferation by inactivating eNOS via reduction of both intracellular
Ca2+ levels and eNOS phosphorylation at Ser1179
, Pharmaceuticals, August 2011; (4), 1052-1059
3. Rivera JC, Aranda J, Riesgo J, Nava G, Thebault S, López-Barrera F, Ramírez M, Martínez de la Escalera G, Clapp C , Expression and cellular localization of prolactin and the prolactin receptor in mammalian retina, Experimental Eye Research, January 2008; (86), 314-21
4. Jacobi JS, Martin C, Nava G, Jeziorski MC, Clapp C & Martínez de la Escalera G, 17b-Estradiol directly regulates the expression of adrenergic and kisspeptin receptors in GT1-7 GnRH neurons, Endocrinology, January 2007; (86), 260–269
5. Martin C, Jacobi JS, Nava G, Jeziorski MC, Clapp C & Martínez de la Escalera G , GABA Inhibition of Cyclic AMP Production in Immortalized GnRH Neurons is Mediated by Calcineurin-Dependent Dephosphorylation of Adenylyl Cyclase 9, Neuroendocrinology, January 2007; 85(85), 257-66
...more
Publicaciones
...less
1. Triebel J, Moreno-Vega AI, Vázquez-Membrillo M, Nava G, García-Franco R, López-Star E, Baldivieso-Hurtado O, Ochoa D, Macotela Y, Bertsch T, Martinez de la Escalera G, Clapp C., High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function., Clinical Laboratory, August 2015; 61(7), 709-16
2. Thebault S, González C, García C, Arredondo Zamarripa D, Nava G, Vaca L, López-Casillas F, Martínez De La Escalera G, Clapp C., Vasoinhibins prevent bradykinin-stimulated endothelial cell proliferation by inactivating eNOS via reduction of both intracellular
Ca2+ levels and eNOS phosphorylation at Ser1179
, Pharmaceuticals, August 2011; (4), 1052-1059
3. Rivera JC, Aranda J, Riesgo J, Nava G, Thebault S, López-Barrera F, Ramírez M, Martínez de la Escalera G, Clapp C , Expression and cellular localization of prolactin and the prolactin receptor in mammalian retina, Experimental Eye Research, January 2008; (86), 314-21
4. Jacobi JS, Martin C, Nava G, Jeziorski MC, Clapp C & Martínez de la Escalera G, 17b-Estradiol directly regulates the expression of adrenergic and kisspeptin receptors in GT1-7 GnRH neurons, Endocrinology, January 2007; (86), 260–269
5. Martin C, Jacobi JS, Nava G, Jeziorski MC, Clapp C & Martínez de la Escalera G , GABA Inhibition of Cyclic AMP Production in Immortalized GnRH Neurons is Mediated by Calcineurin-Dependent Dephosphorylation of Adenylyl Cyclase 9, Neuroendocrinology, January 2007; 85(85), 257-66
6. Macotela Y, Aguilar MB, Guzman-Morales J, Rivera JC, Zermeño C, Lopez-Barrera F, Nava G, Lavalle C, Martinez de la Escalera G & Clapp C , Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin, Journal Of Cell Science, January 2006; (119), 1790-800
7. Zermeño C,Guzman-Morales J, Macotela Y, Nava G, Lopez-Barrera F, Kouri JB, Lavalle C, Martínez de la Escalera G & Clapp C , Prolactin inhibits the apoptosis of chondrocytes induced by serum starvation, J Endocrinol, January 2006; R1-8(R1-8), 189
8. Aranda J., Rivera J. C., Jeziorski M. C., Riesgo J., Nava G., López-Barrera F., Quiroz-Mercado H., Berger P., Martínez de la Escalera G. and Clapp C, Prolactins are natural inhibitors of angiogenesis in the retina, Investigative Ophthalmology & Visual Science, January 2005; 46(0), 2947-2953
9. Montes de Oca P., Macotela Y., Nava G., López-Barrera F., Martínez de la Escalera G., Clapp C., PROLACTIN STIMULATES INTEGRIN-MEDIATED ADHESION OF CIRCULATING MONONUCLEAR CELLS TO ENDOTHELIAL CELLS., Laboratory Investigation, January 2005; 85(0), 633-642
10. Dueñas Z., Rivera J.C., Quiróz-Mercado H., Aranda J., Macotela Y., Montes de Oca P., López-Barrera F., Nava G., Guerrero J.L., Suárez A., De Regil M., Martínez de la Escalera G., Clapp C., Prolactin in the eye of patients with retinopathy of prematurity: Implications for vascular regression., Investigative Ophthalmology & Visual Science, January 2004; 45(7), 2049-2055
11. Torner L., Maloumby R., Nava G., Aranda J., Clapp C., Neumann D.I., In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. , European Journal Of Neuroscience, January 2004; 19(0), 1601-1608
12. Corbacho A.M., Macotela Y., Nava G., Eiserich J.P., Cross C.E, Martínez de la Escalera G., Clapp C., CYTOKINE INDUCTION OF PROLACTIN RECEPTORS MEDIATES PROLACTIN INHIBITION OF NITRIC OXIDE SYNTHESIS IN PULMONARY FIBROBLASTS., Febs Letters, January 2003; 544(0), 171-174
13. Torner L., Toschi N., Nava G., Clapp C., Neumann D.I., INCREASED HYPOTHALAMIC EXPRESSION OF PROLACTIN IN LACTATION: INVOLVEMENT IN BEHAVIOURAL AND NEUROENDOCRINE STRESS RESPONSES., European Journal Of Neuroscience, January 2002; 15(0), 1-11
14. Ochoa A., Montes de Oca P., Rivera J.C., Dueñas Z., Nava G., Martínez de la Escalera G., Clapp C., EXPRESSION OF PROLACTIN GENE AND SECRETION OF PROLACTIN BY RAT RETINAL CAPILLARY ENDOTHELIAL CELLS., Investigative Ophthalmology & Visual Science, January 2001; 42(0), 1639-1645
15. Corbacho A.M., Macotela Y., Nava G., Torner L., Dueñas Z., Noris G.F., Morales M.A., Martínez de la Escalera G., Clapp C., HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS EXPRESS MULTIPLE PROLACTIN-LIKE ISOFORMS., Journal Of Endocrinology, January 2000; 166(0), 53-62
16. Corbacho A.M., Nava G., Eiserich J.P., Noris G.F., Macotela Y., Struman I., Martínez de la Escalera G., Freeman B.A., Clapp C., PROTEOLYTIC CLEAVAGE CONFERS NITRIC OXIDE SYNTHASE INDUCTING ACTIVITY UPON PROLACTIN., Journal Of Biological Chemistry, January 2000; 275(0), 13183-13186
17. Torner L., Nava G., Dueñas Z., Corbacho A., Mejía S., López F., Cajero M., Martínez de la Escalera G., Clapp C., CHANGES IN THE EXPRESSION OF NEUROHYPOPHYSEAL PROLACTINS DURING THE ESTROUS CYCLE AND AFTER ESTROGEN TREATMENT., Journal Of Endocrinology, January 1999; 161(3), 423-432